Vitrectomy with silicone oil infusion in severe diabetic retinopathy.

@article{Castellarin2003VitrectomyWS,
  title={Vitrectomy with silicone oil infusion in severe diabetic retinopathy.},
  author={Alessandro Castellarin and Ruben A Grigorian and Neel Bhagat and Luc{\'i}a del Priore and Marco Attilio Zarbin},
  journal={The British journal of ophthalmology},
  year={2003},
  volume={87 3},
  pages={318-21}
}
AIMS To determine the results of pars plana vitrectomy (PPV) and silicone oil infusion (SOI) in severe proliferative diabetic retinopathy (PDR). METHODS The records of 23 eyes (21 patients: 12 males, nine females) with PDR who had undergone PPV and SOI were reviewed retrospectively. RESULTS Average follow up was 5.4 months (range 1-25). Surgical indications were tractional retinal detachment (TRD) (17.4%), traction-rhegmatogenous retinal detachment (TRRD) (8.7%), TRD with vitreous… CONTINUE READING

2 Figures & Tables

Connections & Topics

Mentioned Connections BETA
EyeNo subtypeRetina
Among these 23 eyes , 11 ( 48% ) had previously failed vitrectomy , and the retina was attached in 8/11 ( 73% ) with a single procedure .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
RetinaNo subtypeEye
Among these 23 eyes , 11 ( 48% ) had previously failed vitrectomy , and the retina was attached in 8/11 ( 73% ) with a single procedure .
RetinaAnatomic structure is physical part ofEye
Among these 23 eyes , 11 ( 48% ) had previously failed vitrectomy , and the retina was attached in 8/11 ( 73% ) with a single procedure .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
RetinaIs associated anatomic site ofRetinal Diseases
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
RetinaIs associated anatomic site ofRhegmatogenous retinal detachment
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
RetinaIs associated anatomic site ofTractional retinal detachment
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
Surgical indications were tractional retinal detachment ( TRD ) ( 17.4% ) , traction - rhegmatogenous retinal detachment ( TRRD ) ( 8.7% ) , TRD with vitreous haemorrhage ( VH ) ( 48% ) , TRD with neovascular glaucoma ( NVG ) ( 8.6% ) , TRD with fibrinoid syndrome ( FS ) ( 17.3% ) .
All Topics